24.9 C
New York
Thursday, June 4, 2026

Tag: campo

Constellation Brands to Report First Quarter Fiscal 2027 Financial Results on June 30, 2026 After Market Close and Host Conference Call on July 1,...

ROCHESTER, N.Y., June 02, 2026 (GLOBE NEWSWIRE) -- Constellation Brands, Inc. (NYSE: STZ), a leading beverage alcohol company, announced today it will report financial results for its first quarter ended May 31, 2026, on Tuesday, June 30, 2026, after the close of the U.S. markets by posting the earnings release and financial tables, as well as other supporting materials, on the company’s investor relations website at ir.cbrands.com. A live conference call will be hosted at 8:00 a.m. ET on Wednesday, July 1, 2026, for analysts to discuss the company’s financial results, operating performance, strategic business initiatives, and financial outlook with President and Chief Executive Officer, Nicholas Fink, and Executive Vice President and Chief Financial Officer, Garth Hankinson.

Locksley To Expand Exploration of Rare Earths Potential in Mojave North Block

Key Highlights Structural and geological field mapping campaign expected to commence late this month to define high priority rare earth elements (REE) and antimony target...

Locksley Appoints Tribeca Capital to Support U.S. Critical Minerals Growth Strategy Strategy

SAN BERNARDINO, Calif., Aug. 7, 2025 /PRNewswire/ -- Locksley Resources Ltd. (ASX: LKY; OTCQB: LKYRF) announced it has appointed Tribeca Capital Pte. Ltd. (Tribeca...

Locksley Accelerates U.S. Critical Minerals Program with Expanded Desert Antimony Drilling

SAN BERNARDINO, Calif., Aug. 4, 2025 /PRNewswire/ -- Locksley Resources (ASX: LKY; OTCQB: LKYRF – today announced the company submitted an expanded Plan...

Knight Therapeutics Announces Regulatory Supplemental Submission of MINJUVI® (tafasitamab) for Follicular Lymphoma in Brazil

MONTREAL, July 31, 2025 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltda., has submitted a supplemental application to ANVISA, the Brazilian health regulatory agency, seeking approval for an additional indication for MINJUVI® (tafasitamab) in combination with rituximab and lenalidomide for the treatment of adult patients with previously treated follicular lymphoma (FL). The supplemental application for the additional indication was selected for review under Project Orbis.

Corby Announces Fourth Quarter & Year-End 2025 Results Release Date and Conference Call

TORONTO, July 23, 2025 /CNW/ - Corby Spirit and Wine Limited ("Corby" or the "Company") (TSX: CSW.A) (TSX: CSW.B) announced today that it will report its 2025...

Jameson® Irish Whiskey and Major League Soccer Toast to the Summer of Soccer

Ahead of the 2025 MLS All-Star Game in Austin, Jameson is Fueling Soccer Fandom with Unmatched, New Game Day Sips NEW YORK, July 23, 2025...

TERA-Award: la quarta cerimonia di premiazione si è tenuta a Cambridge

Una startup britannica si aggiudica il Gold Award dal valore di 1 milione di dollari
Una startup britannica si aggiudica il Gold Award dal valore di 1 milione di dollari

Discounted Explorers Poised For Catch‑Up Rally In Bullish Gold Market

USA News Group News CommentaryIssued on behalf of RUA GOLD Inc. VANCOUVER, BC, July 17, 2025 /PRNewswire/ -- USA News Group News Commentary – After a...

Discounted Explorers Poised For Catch‑Up Rally In Bullish Gold Market

USA News Group News CommentaryIssued on behalf of RUA GOLD Inc. VANCOUVER, BC, July 17, 2025 /CNW/ -- USA News Group News Commentary – After a...

Discounted Explorers Poised For Catch‑Up Rally In Bullish Gold Market

USA News Group News CommentaryIssued on behalf of RUA GOLD Inc. VANCOUVER, BC, July 17, 2025 /PRNewswire/ -- USA News Group News Commentary – After a...

Redbreast Irish Whiskey Joins TIFF as the Official Whiskey of the Festival!

TORONTO, July 16, 2025 /CNW/ - In a celebration of heritage, craft, and storytelling, Redbreast Single Pot Still Irish Whiskey proudly joins the 50th edition...

ZenaTech reacciona al memorando “Impulsando el dominio de drones militares en EE. UU.”: una directiva de política revolucionaria para ZenaDrone

VANCOUVER, British Columbia, July 12, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), un proveedor de soluciones de tecnología empresarial especializado en drones con IA (Inteligencia Artificial), Drones como un Servicio (DaaS), soluciones empresariales SaaS y computación cuántica, reacciona hoy a la nueva directiva de política, del 10 de julio de 2025 del Secretario de Defensa, Pete Hegseth, 'Impulsando el dominio de drones militares en EE. UU'. ZenaTech confirma que, bajo esta directiva de política, toda su cartera de drones ZenaDrone califica como activos prescindibles del Grupos 1–2 y ahora están habilitados para compras directas por comandantes de campo, tanto para capacitación como para misiones en el mundo real, y ya no necesitan la certificación Green o Blue UAS (Sistemas Aéreos No Tripulados).

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsCampo